Viewing Study NCT04223804

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:57 PM
Ignite Modification Date: 2026-02-08 @ 8:01 PM
Study NCT ID: NCT04223804
Status: COMPLETED
Last Update Posted: 2023-03-09
First Post: 2020-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Human Immunodeficiency Virus (HIV) View
None HIV Infection View
None HIV-1 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Human Immunodeficiency Virus (HIV) View
None HIV Infection View
None HIV-1 View
None ABBV-181 View
None Analytical Treatment Interruption View
None Budigalimab View
None Programmed cell death protein-1 (PD-1) View
None Anti-PD-1 Antibody View